Hangzhou, China

Shenggan Wu

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shenggan Wu

Introduction

Shenggan Wu is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of chemistry, particularly with his innovative patent. His work reflects a commitment to advancing scientific knowledge and practical applications.

Latest Patents

Shenggan Wu holds a patent for "2-Pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses." This invention showcases his expertise in developing chemical compounds with potential applications in various industries. The patent highlights his ability to create novel solutions that can address specific challenges in the field.

Career Highlights

Throughout his career, Shenggan Wu has demonstrated a strong dedication to research and innovation. His work has led to the development of unique chemical derivatives that can be utilized in multiple applications. With a focus on practical uses, he has positioned himself as a valuable contributor to the scientific community.

Collaborations

Shenggan Wu has collaborated with notable colleagues, including Yong Wu and Jun Wu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise. Such collaborations are essential for driving innovation and enhancing the impact of their collective work.

Conclusion

Shenggan Wu's contributions to the field of chemistry through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to inspire advancements in chemical research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…